Improving access to medical innovation in Central and Eastern Europe

Easier access to medicines and technology would improve health outcomes in Central and Eastern Europe. Prioritising cost saving measures in the short-term ignores the benefits of new technologies on both healthcare costs and patient outcomes in the long-term. In order to ensure equal access to innovative medicines across Europe, Central and Eastern European governments should consider measures like reference pricing and health technology assessments. Improving access while bringing down costs will also require coordination and transparency with multiple stakeholders within each country and across the region. Read our publication with Economist Impact for more.